Nomura Holdings Inc. Buys New Position in Doximity, Inc. (NASDAQ:DOCS)

Nomura Holdings Inc. acquired a new stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 17,002 shares of the company's stock, valued at approximately $908,000.

A number of other hedge funds have also recently made changes to their positions in the business. QSV Equity Investors LLC grew its holdings in shares of Doximity by 0.3% during the fourth quarter. QSV Equity Investors LLC now owns 60,763 shares of the company's stock valued at $3,244,000 after buying an additional 186 shares during the last quarter. Handelsbanken Fonder AB boosted its stake in Doximity by 0.7% during the 4th quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company's stock valued at $1,586,000 after purchasing an additional 200 shares during the last quarter. UMB Bank n.a. boosted its stake in Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after purchasing an additional 235 shares during the last quarter. Fielder Capital Group LLC boosted its stake in Doximity by 4.5% during the 4th quarter. Fielder Capital Group LLC now owns 5,488 shares of the company's stock valued at $293,000 after purchasing an additional 235 shares during the last quarter. Finally, Larson Financial Group LLC boosted its stake in Doximity by 49.4% during the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after purchasing an additional 250 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Stock Performance

NASDAQ DOCS traded up $0.46 during trading on Thursday, hitting $51.21. 2,652,525 shares of the company's stock traded hands, compared to its average volume of 2,095,296. The stock has a market capitalization of $9.56 billion, a price-to-earnings ratio of 51.21, a PEG ratio of 4.10 and a beta of 1.41. The business has a 50 day moving average of $56.78 and a 200-day moving average of $57.94. Doximity, Inc. has a 12-month low of $25.00 and a 12-month high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its earnings results on Thursday, May 15th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. The company's revenue for the quarter was up 17.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.25 EPS. On average, analysts expect that Doximity, Inc. will post 0.99 EPS for the current year.

Insider Transactions at Doximity

In related news, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total value of $113,860.00. Following the sale, the director now owns 16,618 shares in the company, valued at approximately $946,062.74. This trade represents a 10.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Anna Bryson sold 45,000 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total value of $2,575,350.00. Following the completion of the sale, the chief financial officer now owns 357,165 shares in the company, valued at $20,440,552.95. This trade represents a 11.19% decrease in their position. The disclosure for this sale can be found here. Insiders own 37.40% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on DOCS. Canaccord Genuity Group cut their price target on Doximity from $71.00 to $50.00 and set a "hold" rating for the company in a research note on Friday, May 16th. Leerink Partners raised shares of Doximity from a "market perform" rating to an "outperform" rating and lifted their price objective for the stock from $60.00 to $90.00 in a report on Friday, February 7th. Mizuho cut their price objective on shares of Doximity from $65.00 to $60.00 and set a "neutral" rating on the stock in a report on Friday, May 16th. William Blair reaffirmed an "outperform" rating on shares of Doximity in a report on Friday, May 16th. Finally, Needham & Company LLC cut their target price on Doximity from $82.00 to $67.00 and set a "buy" rating on the stock in a research note on Friday, May 16th. Eleven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $61.22.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.